Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Erlotinib HCl (compound)
Most Correlated Studies
- Gene expression in EGFR inhibitor resistant or sensitive pancreatic cancer
- Dermal fibroblasts treated with the tyrosine kinase inhibitor erlotinib
- Livers of rat exposed to variety of hepatotoxic compounds
- Bronchial epithelial cells with erlotinib-induced quiescence or senescence
- Lung cancer PC-9 parental cells or drug-treated and drug-tolerant persister (DTP) subpopulations
Most Relevant Literature
- Erlotinib-associated interstitial pneumonitis with successful readministration.
- Development of erlotinib-loaded nanotransferosomal gel for the topical treatment of ductal carcinoma…
- A meta-analysis and systematic review of randomized controlled trials in combination gemcitabine wit…
- Development of a molecularly imprinted electrochemical sensor for erlotinib detection using a modifi…
- Preparation of Erlotinib hydrochloride nanoparticles (anti-cancer drug) by RESS-C method and investi…
Most Relevant Clinical Trials
- Phase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC)
- A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following…
- Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
- A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Smal…
- Erlotinib (Tarceva (Trademark), OSI-774) in Treating Patients With Advanced Non-Small Cell Lung Canc…
